PAPPA and trisomy 21: Our study demonstrated that when abnormal biomarkers were defined as free β-hCG MoM ≥ 2.75 or PAPP-A MoM ≤ 0.5 in both serum biochemical screening and CFTS group, the detection rate of trisomy 21 was optimal.